Category Archives: Press Releases

Amoneta closes 2019 with a total fundraising of € 2,2 million ABA* joins the Amoneta investors on Dec 27th, 2019

            Huningue/FRANCE January 11th, 2020 Amoneta Diagnostics S.A.S., an affiliate of Firalis Group, announces a new funding from Alsace Business Angels (ABA Invest 4), who joins Amoneta’s historical investors, SODIV and ADDF, on Dec 27th, 2019. Amoneta Diagnostics develops for commercial launch, several non-invasive biomarker-based blood tests and other tools…
Read more

FIRALIS S.A. appoints Alain FOURNELLE as Chief Financial Officer

    Huningue, France, July 31st, 2019 - Firalis S.A (“Firalis”), a developer of biomarker-based products and provider of biomarker services announces the appointment of Alain Fournelle as new Chief Financial Officer. Alain has three decades of financial expertise in various fields of financial recovery, due diligence and mergers & acquisitions as consultant at E&Y…
Read more

Amoneta Diagnostics has been awarded up to of USD 2 million by the Alzheimer’s Drug Discovery Foundation (ADDF)

      In support of the MemoryLINC project “Validation of a Rapid Non-Invasive Diagnostic Test to Predict Mild-Cognitive Impairment and Early Alzheimer's Disease”, Amoneta Diagnostics S.A.S. has been awarded up to of USD 2 million by the Alzheimer’s Drug Discovery Foundation (ADDF) Diagnostics Accelerator Huningue, May 31st, 2019 – Amoneta Diagnostics SAS, an affiliate…
Read more